Welcome to CardioRenal

Digital therapeutics for chronic cardiovascular disease

CardioRenal is a company that develops and markets digital therapeutics solutions for chronic disease management.

We want to improve chronic patient treatment at home

CardioRenal uses the most advanced technologies to develop digital therapeutic solutions allowing chronic patient at home to benefit from a personalized medicine

Our shared vision is that now is the time to help chronic patients to have a better healthcare delivery at home.

“ Long term patient engagement in their disease management is within our reach ”

Chronic kidney disease

Cardiorenal’ s mission is to improve chronic patient care with our unique digital therapeutic solutions relying on blood biomarkers monitored at home

Around 700 million

People with chronic kidney disease in the world¹, with likely many more still undiagnosed

Expenses

2- 3% of annual heathcare budget spent in end stage renal disease treatment²

Treatment

Up to 40-50% with CKD may be affected by hyperkalemia and have under-dosed life saving drugs treatment^3,4

Cardiovascular

Associated events account four up to 30% of death in patients with CKD⁵

Bikbov B et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2020; 395(10225):709–33
Bello AK et al. Global Kidney Health Atlas: A report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. Brussels, Belgium: International Society of Nephrology; 2017. Available from: URL: www.theisn.org/global-atlas.
National Kidney Foundation. Facts About High Potassium in Patients with Kidney Disease [cited 16 Oct 2020]. Available from: URL: https://www.kidney.org/atoz/content/hyperkalemia/facts.
Pecoits-Filho R et al. Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care. J Clin Hypertens (Greenwich). 2019;21(7):991-1001.
Thompson S et al. Cause of Death in Patients with Reduced Kidney Function. J Am Soc Nephrol 2015; 26(10):2504–11.